Abstract
Two different oral doses of oleoyl-estrone: 1 and 10 nmol/g a day were given once to male Wistar rats. the serum levels of free estrone, estrone sulphate, estradiol, and acyl-estrone were measured at intervals up to 72 h after the gavage. Oleoyl-estrone was rapidly absorbed; with the 1 nmol/g dose no changes were observed in plasma acyl-estrone but levels increased dramatically with 10 nmol/g, peaking at 6 h; high acyl-estrone levels were maintained up to 24 h, returning to normalcy at 48 h. With the 10 nmol/g dose, free estrone at most doubled its levels but estrone sulphate concentrations rose by one order of magnitude; in both cases, the increases soon (2 h) reached a plateau that was maintained for almost two days. Estradiol levels remained unchanged except for a transient peak at 2 h at the 10 nmol/g dose. The relationship between free estrone and its sulphate was linear, and those of estrone and estrone sulphate versus acyl-estrone showed the existence of an upper serum concentration limit for both molecules. The results hint at estrone sulphate being an important metabolite of oleoyl-estrone disposal, confirm the limited estrogenic response to oleoyl-estrone administration and agree with a rapid absorption and disposal of oleoyl-estrone, nevertheless maintaining high circulating levels of the ester for a time after its oral administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sanchis D, Balada F, del Mar Grasa M, et al. Oleoyl-estrone induces the loss of body fat in rats. Int J Obes Relat Metab Disord 1996, 20: 588–94.
Esteve M, Savall P, Blay MT, Fernández-López JA, Remesar X, Alemany M. Intestinal handling of an oral oleoyl-estrone gavage by the rat. Life Sci 2001, 69: 763–77.
Ferrer-Lorente R, García-Peláez B, Gómez-Ollés S, Fernández-López JA, Remesar X, Alemany M. Effects of oral estrone on rat energy balance. Steroids 2005, 70: 667–72.
Grasa MM, Cabot C, Esteve M, et al. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. Obes Res 2001, 9: 202–9.
Remesar X, Tang V, Ferrer E, et al. Estrone in food: a factor influencing the development of obesity? Eur J Nutr 1999, 38: 247–53.
García-Peláez B, Ferrer-Lorente R, Gómez-Ollés S, Fernández-López JA, Remesar X, Alemany M. Technical note: Measurement of total estrone content in foods. Application to dairy products. J Dairy Sci 2004, 87: 2331–6.
Andersson S, Moghrabi N. Physiology and molecular genetics of 17β-hydroxysteroid dehydrogenases. Steroids 1997, 62: 143–7.
Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, Bélanger A. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997, 62: 148–58.
Cabot C, Grasa MM, Massanés RM, et al. Oleoyl-estrone does not have direct estrogenic effects on rats. Life Sci 2001, 69: 749–61.
Alemany M, Fernández-López JA, Petrobelli A, Granada M, Foz M, Remesar X. Pérdida de peso en un paciente con obesidad mórbida en tratamiento con oleoil-estrona. Med Clin (Barc) 2003, 121: 496–9.
Massanés RM, Grasa MM, López-Martí J, et al. Zucker obese rats store less acyl-estrone than lean controls. Int J Obes Relat Metab Disord 2003, 27: 428–32.
Remesar X, Guijarro P, Torregrosa C, et al. Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet. Int J Obes Relat Metab Disord 2000, 24: 1405–12.
Ardévol A, Virgili J, Sanchis D, Adán C, et al. A method for the measurement of plasma estrone fatty ester levels. Anal Biochem 1997, 249: 247–50.
Cabot C, Salas A, Ferrer-Lorente R, et al. Short-term oral oleoyl-estrone treatment increases plasma cholesterol turnover in the rat. Int J Obes (Lond) 2005, 29: 534–9.
Peltoketo H, Vihko P, Vihko R. Regulation of estrogen action: role of 17β-hydroxysteroid dehydrogenases. Vitam Horm 1999, 55: 353–98.
Ferrer-Lorente R, García Peláez B, Fernández-López JA, Remesar X, Alemany M. Tamoxifen does not prevent the mobilization of body lipids elicited by oleoyl-estrone. Steroids 2004, 69: 661–5.
van den Belt K, Berckmans P, Vangenechten C, Verheyen R, Witters H. Comparative study on the in vitro/in vivo estrogenic potencies of 17 beta-estradiol, estrone, 17 alpha-ethynylestradiol and nonylphenol. Aquat Toxicol 2004, 66: 183–95.
Li W, Seifert M, Xu Y, Hock B. Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays. Environ Int 2004, 30: 329–35.
Hernández JS, Watson RWG, Wood TC, Weinshilboum RM. Sulfation of estrone and 17β-estradiol in human liver. Catalysis by thermostable phenol sulfotransferase and by de-hydroepiandrosterone sulfotransferase. Drug Metab Dispos 1992, 20: 413–22.
Longcope C. The metabolism of estrone sulfate in normal males. J Clin Endocrinol 1972, 34: 113–22.
Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hämäläinen E. Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 1994, 86: 1076–82.
Zhu BT, Bui QD, Weisz J, Liehr JG. Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesis. Endocrinology 1994, 135: 1772–9.
Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17 beta-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 2003, 144: 3382–98.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cabot, C., González-Martínez, D., Fernández-López, J.A. et al. In the rat, estrone sulphate is the main serum metabolite of oral oleoyl-estrone. J Endocrinol Invest 30, 376–381 (2007). https://doi.org/10.1007/BF03346313
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346313